Executive Overview

Fischer Medical Ventures Limited (FMV) presents itself as an integrated AI-enabled healthcare platform spanning medical imaging, population-scale screening, and hospital digitization. The company's vision is to make early detection and preventive healthcare universally accessible through intelligent, integrated, and affordable medical technology.

Corporate Structure and Leadership

The FMV Group operates as an integrated healthcare innovation ecosystem across diagnostics, AI, biologics, and international ventures.

Board of Directors:

  • Chairman & Managing Director: Ravindran Govindan
  • Whole Time Director: Svetlana Rao Raviwada (former roles at Wipro & Alcatel R&D)
  • Independent Directors: Khairy Jamaluddin Abu Bakar, Jaya Ankur Singhania, Richard Chan Sing En, Dr. Syed Jalaluddin

Key Managerial Personnel:

  • Company Secretary and Compliance Officer: Balaji Gandla
  • FMV Group Chief Operating Officer: Roberto M. Pagdanganan (30+ years in investment banking, project financing)
  • FMV Group Chief Financial Officer: Vivek Balasubramanian (Chartered Accountant, ex-PWC and KPMG M&A)
  • Chief Technology Officer-Time Medical: Simon Yeung (co-founder with 20+ years MRI experience)
  • Chief Operating Officer-Time Medical: Amol Mhaskar (13+ years field engineering expertise)
  • Chief Technology Officer-Flynncare: Alagaraja Ravindra Raja (20+ years healthcare experience)
  • Chief Solutions Architect-Flynncare: Karthikeyan R (19+ years healthcare product development)
  • VP-Plant Operations-Time Medical: Commander Yogendra Sharma (20+ years Indian Navy experience)

Medical Imaging Portfolio

MRI Diagnostic Range:

  • PICA/PANION/AURA: 0.35T/0.7T open architecture systems (FDA/CE/CDSCO approvals)
  • MICA/MICA Smart: 1.5T general-purpose high performance (CDSCO approved)
  • QUIN: 1.5T helium-free high-performance neurology & cardiac (CDSCO approved)
  • NEONA: Specialized MRI
  • NEXA/N-NEXA: 3.0T MRI
  • Nova 7T: 7.0T ultra-high field research platform

Screening Solutions:

  • VEGA, VEGA+ and MMIS: Purpose-built for stroke, vascular and population screening

Surgical Innovation:

  • Medharanya Suite & Intraoperative MRI: DRIS, DRIS+ integrated neuro-surgical ecosystem

CT Imaging Portfolio:

  • Clarion CT family: From 32-slice to wide-bore configurations

X-Ray Portfolio:

  • Portable X-Ray: Battery-powered portable devices (150+ images per charge)
  • RX series: RX90, RX706, RX590, RX910 (CDSCO, BIS, AERB approvals)
  • C-ARM: 40-125 kV capability (CDSCO, BIS, AERB approvals)
  • AI-enabled imaging with pre-read AI for TB, pneumonia, fractures

Mammography Solutions:

  • Navigator series: AI-assisted breast cancer screening and tomosynthesis

Technology Platforms

MIDAS - Unified AI Healthcare Screening Ecosystem:

Multi-disciplinary early disease detection through single screening workflow including:

  • Oral Cancer: Smartphone imaging + AI lesion classification
  • Breast Cancer: AI density + lesion analysis on mammography
  • Cervical Screening: Colposcopy AI + HPV risk integration
  • AI Fundus: Diabetic retinopathy + glaucoma + AMD screening
  • Cardiac Risk: ECG + biomarkers + AI risk scoring
  • Neuropathy: Sensory testing + AI peripheral neuropathy detection

LIVE Dx - Population Screening Platform:

Population-scale screening with tele-health, remote monitoring and predictive analytics

Clinics 2.0 Platform:

Specialty EHR, HIS, practice management, telemedicine, AI insights and device interoperability

ATLAS - AI Healthcare Analytics Platform:

Four-stage analytics maturity from descriptive to prescriptive analytics

Additional Business Lines

NanoMedic - SpinCare Regenerative Skin Technology:

World's first portable electrospinning system for direct-to-patient regenerative skin substitute application

Obelab - Portable Brain Imaging Platform:

Functional near-infrared (fNIRS) and cerebral oximetry devices for research and clinical mental-health care

Nervotec - Contactless Vital Signs Measurement:

Predictive healthcare via 60-second facial scan measuring HR, HRV, Respiration Rate, SpO₂, Stress, Emotional State

Nanyang Biologics - AI Drug Discovery Platform:

Next-generation natural-compound drug discovery built on NVIDIA + HPE infrastructure with NTU joint research

CareViva Nutraceutical Portfolio:

Evidence-based nutraceutical products across four lines:

  • Oncology: Tumor protection, proven efficacy in inhibiting tumor growth
  • Metabolic Health: AdiCare for adipose health, proven efficacy in browning white fat
  • Liver Health: LivHealth for fatty liver reversal, proven efficacy in lipid clearance
  • Cardiovascular: CardoaViva for foam cell prevention, proven efficacy in atherosclerosis prevention

Implementation Frameworks

4T4TB - TB Screening Framework:

Trace, Test, Treat, Track - AI-enabled portable X-ray driven workflow

SHIELD - Cancer Screening Framework:

Screen, Highlight, Investigate, Empower, Long-term monitoring, Develop

Corporate Health Screening:

Workforce wellness, women's health, mental wellness and ESG-linked healthcare services

Disclaimer

The presentation contains forward-looking statements subject to risks and uncertainties including government actions, local political or economic developments, technological risks, and other factors that could cause actual results to differ materially from those contemplated.